Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.

Publication

Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.

Journal Paper/Review - Mar 2, 2023

Dhayat Nasser A, Bonny Olivier, Roth Beat, Christe Andreas, Ritter Alexander, Mohebbi Nilufar, Faller Nicolas, Pellegrini Lisa, Bedino Giulia, Venzin Reto M, Grosse Philipp, Hüsler Carina, Koneth Irene, Bucher Christian, Del Giorno Rosaria, Gabutti Luca, Mayr Michael, Odermatt Urs, Buchkremer Florian, Ernandez Thomas, Stoermann-Chopard Catherine, Teta Daniel, Vogt Bruno, Roumet Marie, Tamò Luca, Cereghetti Grazia M, Trelle Sven, Fuster Daniel G

Citation

Dhayat N, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N, Faller N, Pellegrini L, Bedino G, Venzin R, Grosse P, Hüsler C, Koneth I, Bucher C, Del Giorno R, Gabutti L, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Vogt B, Roumet M, Tamò L, Cereghetti G, Trelle S, Fuster D. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. N Engl J Med 2023; 388:781-791.

Type

Journal Paper/Review (English)

Journal

N Engl J Med 2023; 388

Publication Date

Mar 2, 2023

Issn Electronic

1533-4406

Pages

781-791

Brief description/objective

Nephrolithiasis is one of the most common conditions affecting the kidney and is characterized by a high risk of recurrence. Thiazide diuretic agents are widely used for prevention of the recurrence of kidney stones, but data regarding the efficacy of such agents as compared with placebo are limited. Furthermore, dose-response data are also limited.